WIN Consortium shared on X:
“Early Bird Registration for WIN Symposium 2026 closes on August 16, 2026. Poster abstract submission has been extended to August 21, 2026.
Explore Translational Oncology.
This session will highlight translational research, clinical trial design, novel therapies, and the application of precision oncology across cancer types.
Session speakers include:
Dr. Giuseppe Curigliano – University of Milano, European Institute of Oncology, Milan, Italy, President-Elect, ESMO 2027-2028
Dr. Benedito A. Carneiro – Legorreta Cancer Center, Brown University, Providence, RI, USA
Dr. Jennifer Grandis – University of California San Francisco, San Francisco, CA, USA
Dr. Kornelia Polyak – Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA
WIN Symposium 2026 is endorsed by ASCO, supporting the scientific positioning of this year’s program. Register by August 16 to secure the Early Bird rate. Submit your poster abstract by August 21.”
